Vidya Mamidipudi

801 total citations
14 papers, 673 citations indexed

About

Vidya Mamidipudi is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Vidya Mamidipudi has authored 14 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Immunology. Recurrent topics in Vidya Mamidipudi's work include Protein Kinase Regulation and GTPase Signaling (4 papers), NF-κB Signaling Pathways (4 papers) and Cell death mechanisms and regulation (3 papers). Vidya Mamidipudi is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (4 papers), NF-κB Signaling Pathways (4 papers) and Cell death mechanisms and regulation (3 papers). Vidya Mamidipudi collaborates with scholars based in United States, Switzerland and Italy. Vidya Mamidipudi's co-authors include Marie W. Wooten, Christine A. Cartwright, M. Lamar Seibenhener, María T. Díaz‐Meco, Philip A. Barker, Jorge Moscat, Xiaoxia Li, Kelly C. Lee, Jian Zhang and Carla Heise and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Molecular and Cellular Biology.

In The Last Decade

Vidya Mamidipudi

14 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vidya Mamidipudi United States 11 400 162 141 120 102 14 673
Sonia Pagliardini Italy 17 610 1.5× 312 1.9× 77 0.5× 109 0.9× 133 1.3× 25 988
Patrick Joost Sweden 10 251 0.6× 146 0.9× 119 0.8× 178 1.5× 96 0.9× 13 584
Kiwon Jo United States 9 418 1.0× 190 1.2× 100 0.7× 43 0.4× 90 0.9× 10 767
Sai Latha Shankar United States 8 338 0.8× 84 0.5× 103 0.7× 128 1.1× 79 0.8× 8 727
Armelle Le Guelte France 11 276 0.7× 136 0.8× 57 0.4× 40 0.3× 112 1.1× 11 479
Michayla R. Williams United Kingdom 5 699 1.7× 112 0.7× 52 0.4× 90 0.8× 69 0.7× 7 847
Tilahun Jiffar United States 13 371 0.9× 213 1.3× 93 0.7× 41 0.3× 111 1.1× 14 636
Rainer Apfel Germany 13 600 1.5× 337 2.1× 71 0.5× 91 0.8× 132 1.3× 20 1.0k
Peterson Pathrose United States 14 399 1.0× 173 1.1× 69 0.5× 63 0.5× 97 1.0× 20 660
Hwai Wen Chang United States 8 516 1.3× 172 1.1× 64 0.5× 72 0.6× 60 0.6× 10 693

Countries citing papers authored by Vidya Mamidipudi

Since Specialization
Citations

This map shows the geographic impact of Vidya Mamidipudi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vidya Mamidipudi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vidya Mamidipudi more than expected).

Fields of papers citing papers by Vidya Mamidipudi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vidya Mamidipudi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vidya Mamidipudi. The network helps show where Vidya Mamidipudi may publish in the future.

Co-authorship network of co-authors of Vidya Mamidipudi

This figure shows the co-authorship network connecting the top 25 collaborators of Vidya Mamidipudi. A scholar is included among the top collaborators of Vidya Mamidipudi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vidya Mamidipudi. Vidya Mamidipudi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Carey, S., Sarah J. Richardson, Carla Heise, et al.. (2012). Single‐agent lenalidomide in relapsed/refractory mantle cell lymphoma: results from a UK phase II study suggest activity and possible gender differences. British Journal of Haematology. 159(2). 154–163. 76 indexed citations
2.
Mamidipudi, Vidya, Tao Shi, Helen Brady, et al.. (2011). Increased cellular accumulation and distribution of amrubicin contribute to its activity in anthracycline-resistant cancer cells. Cancer Chemotherapy and Pharmacology. 69(4). 965–976. 8 indexed citations
3.
Buglio, Daniela, Vidya Mamidipudi, Noor M. Khaskhely, et al.. (2010). The class‐I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6‐independent mechanism. British Journal of Haematology. 151(4). 387–396. 44 indexed citations
4.
Mamidipudi, Vidya & Christine A. Cartwright. (2009). A novel pro-apoptotic function of RACK1: suppression of Src activity in the intrinsic and Akt pathways. Oncogene. 28(50). 4421–4433. 54 indexed citations
5.
Buglio, Daniela, Vidya Mamidipudi, Noor M. Khaskhely, et al.. (2009). The Histone Deacetylase Inhibitor MGCD0103 Down Regulates CD30, Activates NF-Kb, and Synergizes with Proteasome Inhibitors by HDAC6 Independent Mechanism in Hodgkin Lymphoma.. Blood. 114(22). 3735–3735. 7 indexed citations
6.
Mamidipudi, Vidya, et al.. (2006). RACK1 inhibits colonic cell growth by regulating Src activity at cell cycle checkpoints. Oncogene. 26(20). 2914–2924. 64 indexed citations
7.
Mamidipudi, Vidya, et al.. (2006). Peptide modulators of Src activity in G1 regulate entry into S phase and proliferation of NIH 3T3 cells. Biochemical and Biophysical Research Communications. 352(2). 423–430. 9 indexed citations
8.
Mamidipudi, Vidya, Betty Chang, Rachel Harte, Kelly C. Lee, & Christine A. Cartwright. (2004). RACK1 inhibits the serum‐ and anchorage‐independent growth of v‐Src transformed cells. FEBS Letters. 567(2-3). 321–326. 18 indexed citations
9.
Mamidipudi, Vidya, et al.. (2004). Regulation of Interleukin Receptor-associated Kinase (IRAK) Phosphorylation and Signaling by Iota Protein Kinase C. Journal of Biological Chemistry. 279(6). 4161–4165. 26 indexed citations
10.
Mamidipudi, Vidya, Jian Zhang, Kelly C. Lee, & Christine A. Cartwright. (2004). RACK1 Regulates G1/S Progression by Suppressing Src Kinase Activity. Molecular and Cellular Biology. 24(15). 6788–6798. 71 indexed citations
11.
Mamidipudi, Vidya & Marie W. Wooten. (2002). Dual role for p75NTR signaling in survival and cell death: Can intracellular mediators provide an explanation?. Journal of Neuroscience Research. 68(4). 373–384. 71 indexed citations
12.
Vandenplas, Michel L., Vidya Mamidipudi, M. Lamar Seibenhener, & Marie W. Wooten. (2002). Nerve growth factor activates kinases that phosphorylate atypical protein kinase C. Cellular Signalling. 14(4). 359–363. 10 indexed citations
13.
Mamidipudi, Vidya, Xiaoxia Li, & Marie W. Wooten. (2002). Identification of Interleukin 1 Receptor-associated Kinase as a Conserved Component in the p75-Neurotrophin Receptor Activation of Nuclear Factor-κB. Journal of Biological Chemistry. 277(31). 28010–28018. 66 indexed citations
14.
Wooten, Marie W., M. Lamar Seibenhener, Vidya Mamidipudi, et al.. (2001). The Atypical Protein Kinase C-interacting Protein p62 Is a Scaffold for NF-κB Activation by Nerve Growth Factor. Journal of Biological Chemistry. 276(11). 7709–7712. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026